SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

Credit Suisse Maintains Outperform on Maravai LifeSciences, Raises Price Target to $44

Credit Suisse maintains Maravai LifeSciences (NASDAQ:MRVI) with a Outperform and raises the price target from $42 to $44.

05/11/2021 11:12
Credit Suisse maintains Maravai LifeSciences (NASDAQ:MRVI) with a Outperform and raises the price target from $42 to $44.